N
Neil Pearce
Researcher at University of London
Publications - 795
Citations - 122260
Neil Pearce is an academic researcher from University of London. The author has contributed to research in topics: Population & Asthma. The author has an hindex of 107, co-authored 729 publications receiving 105762 citations. Previous affiliations of Neil Pearce include Harvard University & Victoria University of Wellington.
Papers
More filters
Journal ArticleDOI
Risk of stomach cancer in Aotearoa/New Zealand: A Māori population based case-control study.
Lis Ellison-Loschmann,Andrew Sporle,Marine Corbin,Soo Cheng,Pauline Harawira,Michelle Gray,Tracey Whaanga,Parry Guilford,Jonathan Koea,Neil Pearce +9 more
TL;DR: In this article, the authors used logistic regression to estimate odd ratios (OR) and 95% confidence intervals (CI) between exposures and stomach cancer risk and found that exposure to environmental tobacco smoke was associated with increased stomach risk.
Book ChapterDOI
Confounding and interaction
Neil Pearce,Sander Greenland +1 more
TL;DR: In this article, the basic concepts of confounding and interaction are discussed, and a brief overview of analytic approaches to these phenomena are provided, along with references to relevant chapters in Modern Epidemiology by Rothman and Greenland.
Journal ArticleDOI
Do neighbourhood characteristics act together to influence BMI? A cross-sectional study of urban parks and takeaway/fast-food stores as modifiers of the effect of physical activity facilities.
TL;DR: It is concluded that formal PA facilities may buffer against a lack of informal, green resources for PA in areas where the latter are scarce, and that the potential benefits of formalPA facilities in terms of obesity risk may be undermined by an unhealthy food environment close to home.
Journal ArticleDOI
Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study
Pilar T. V. Florentino,T.G. Millington,Thiago Cerqueira-Silva,Chris Robertson,V. de Araujo Oliveira,Juracy Bertoldo dos Santos Junior,Flávia Jôse Oliveira Alves,Gerson Oliveira Penna,Srinivasa Vital Katikireddi,Viviane Boaventura,Guilherme Loureiro Werneck,Neil Pearce,Colin McCowan,Christopher Sullivan,Utkarsh Agrawal,Zoe Grange,Lewis D Ritchie,Colin R Simpson,Aziz Sheikh,Mauricio Lima Barreto,Igor Rudan,Manoel Barral-Netto,Enny S. Paixão +22 more
TL;DR: W waning vaccine protection of BNT162b2 against symptomatic COVID-19 infection among adolescents in Brazil and Scotland from 27 days after the second dose is found, however, protection against severe CO VID-19 outcomes remained high at 98 days or more after thesecond dose in the omicron-dominant period.